Evaluating the introduction of COVID-19 oral antivirals through a test and treat program: outcomes from a cohort study in four African countries

Evaluating the introduction of COVID-19 oral antivirals through a test and treat program: outcomes from a cohort study in four African countries

Introduction: Access to oral antivirals like nirmatrelvir/ritonavir to treat COVID-19 remains largely unavailable across Africa. Ghana, Malawi, Rwanda and Zambia, all members of the COVID Treatment QuickStart Consortium, leveraged existing infrastructure to rapidly commence COVID-19 test-and-treat p...

Full description

Saved in:
Bibliographic Details
Main Authors: Jessica T. Joseph, Maria Grau-Sepulveda, Bridget C. Griffith, Norman Lufesi, Alexander Martin-Odoom, Nyuma Mbewe, Mwaba Mulenga, Shanti Narayanasamy, Lawrence Ofori-Boadu, Christian Ramers, Edson Rwagasore, Dyson Telela, Sabine Umuraza, Caroline E. Boeke, Cameron R. Wolfe
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:International Journal of Infectious Diseases
Subjects:
LMIC
Nirmatrelvir/ritonavir
pandemic preparedness
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971225001808
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items